±Û ¼öÁ¤Çϱâ
±Û¾´ÀÌ
E-mail
Homepage
±ÛÁ¦¸ñ
±Û
What company are you calling from?
vitalikor vs arginmax
Baird analyst Jeffrey Elliot upgraded his rating on thebiotechnology company's stock to "outperform" from "neutral"saying Chief Executive Chuck Kummeth's strategy, including hisplans to invest in China and other emerging markets, is a goodopportunity for growth.
ºñ¹Ð¹øÈ£
(¼öÁ¤°ú »èÁ¦½Ã ÇÊ¿ä!! )